NCT01033344View on ClinicalTrials.gov

Cat-PAD Exposure Chamber Study

PHASE2CompletedINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Cat Allergy
Interventions
BIOLOGICAL

Placebo

Intradermal injection 1x8 administrations 2 weeks apart

BIOLOGICAL

Cat-PAD

Intradermal injection 1x8 administrations 2 weeks apart

BIOLOGICAL

Cat-PAD

Intradermal injection, 1x8 administrations 2 weeks apart, alternating active and placebo

Trial Locations (1)

L4W 1N2

Cetero Research, Mississauga

Sponsors
All Listed Sponsors
collaborator

Adiga Life Sciences, Inc.

INDUSTRY

collaborator

Cetero Research, San Antonio

NETWORK

lead

Circassia Limited

INDUSTRY

NCT01033344 - Cat-PAD Exposure Chamber Study | Biotech Hunter | Biotech Hunter